Yu M W, Finlayson J S
J Pharm Sci. 1984 Jan;73(1):82-6. doi: 10.1002/jps.2600730122.
Methods were developed for the determination of octanoic acid and N-acetyl-DL-tryptophan, which are used as stabilizers in the human blood-derived therapeutic products normal serum albumin and plasma protein fraction. The method for octanoic acid uses GC; quantitation is achieved using heptanoic acid as the internal standard. The method for N-acetyl-DL-tryptophan is based on UV spectrophotometry of the acid-soluble fraction remaining after precipitation of the protein (epsilon 280 for N-acetyl-DL-tryptophan, 5250). The coefficient of variation for replicate determinations of octanoic acid averaged 3.9% (range 2.1-5.5%); that of N-acetyl-DL-tryptophan averaged 1.9% (range 0.5-4.0%). Use of these methods for the analysis of 138 lots of commercial products for octanoic acid and 159 lots for N-acetyl-DL-tryptophan showed that the stabilizer contents of 132 and 158 of these lots, respectively, were within 20% of the value indicated on the product label.
已开发出用于测定辛酸和N-乙酰-DL-色氨酸的方法,这两种物质在人血源治疗产品人血白蛋白和血浆蛋白组分中用作稳定剂。辛酸的测定方法采用气相色谱法;以庚酸作为内标进行定量。N-乙酰-DL-色氨酸的测定方法基于蛋白质沉淀后剩余酸溶性组分的紫外分光光度法(N-乙酰-DL-色氨酸在280nm处的摩尔吸光系数ε为5250)。辛酸重复测定的变异系数平均为3.9%(范围为2.1%-5.5%);N-乙酰-DL-色氨酸的变异系数平均为1.9%(范围为0.5%-4.0%)。使用这些方法对138批商业产品中的辛酸和159批产品中的N-乙酰-DL-色氨酸进行分析,结果表明,这些批次中分别有132批和158批的稳定剂含量在产品标签所示值的20%以内。